Stephanie Schultz

Massachusetts General Hospital

$258,332

Attributed

$258,332

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $129.2K · FY2024–25

$200K$150K$100K$50K$0

'24

'25

Funding mix

By agency

NIH$258,332 · 1

By mechanism

K01$258,332 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Marilyn S Albert$65,374,594
Oksana Berezovska$14,319,485
Dora M Kovacs$12,707,695
Giuseppina Tesco$13,142,625
Merit E Cudkowicz$97,012,119

Others in their field

Other Rising Stars on “Alzheimer&Apos”

Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
Yanling Wang · Rush University Medical Center$2,986,919
William G Mantyh · University Of Minnesota$2,961,521
Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
Noah Ray Johnson · University Of Colorado Denver$2,282,487

Research focus

Alzheimer&AposS DiseaseAmyloid Beta-42AmyloidBiologicalAmyloid Beta-ProteinAmyloid Precursor Protein ProcessingCareerAutosomal Dominant Alzheimer&AposAutosomeClinical HeterogeneityBiological MarkersBiological ModelsBiologyBiomarker DevelopmentAmyloid Beta-Protein PrecursorCaregiversCatalytic DomainCell ModelCellsCharacteristicsClassificationAlzheimerâS Disease BiomarkerAffect

Grant awards (2)

Identifying variations in gamma-secretase function that are critical determinants of clinical and biomarker progression of Autosomal Dominant Alzheimer's disease: From mechanism to clinical trials$129,166

K01 · FY2025 · AG · contact PI

K01 · FY2024 · AG · contact PI